Engage Bio
mRNA Immunotherapies to Eliminate Cancer
Santa Clara, United States · Founded 2021 · $500K raised
- Headquarters
- Santa Clara, California
- Employees
- 1–10
- Founded
- 2021
- Website
- engagebio.com
- Total Funding
- $500K
- Last Round
- $500K SeedMar 2022
- Rounds
- 1
About
Engage Bio is developing mRNA immunotherapies to defeat cancer. Our founders have deep experience in immunotherapy development, including four drugs in the clinic, and in building mRNA therapeutics platforms. Our approach is to provide cancer cells with instructions to make and gradually release our drugs within solid tumors. This local therapy allows us to eliminate tumors while sparing healthy distant tissues.
Summary
Engage Bio is a Biotech company based in Santa Clara, United States, founded in 2021. It has raised $500K in total across 1 round, most recently a $500K Seed round in Mar 2022.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2022
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...